• 1 Duke-NUS Graduate School of Medicine, Singapore, Singapore
  • 2 Department of Medicine, University of Hong Kong, Pokfulam , Hong Kong
  • 3 Institute of Respiratory Medicine, Kuala Lumpur, Malaysia
  • 4 Department of Pulmonology and Respiratory Medicine, Universitas Indonesia (FMUI), Jakarta, Indonesia
  • 5 Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
  • 6 Respiratory Care Center, University Medical Center, Ho Chi Minh City, Vietnam
  • 7 Takeda Pharmaceuticals (Asia-Pacific) Pte. Ltd, Singapore, Singapore
  • 8 State Key Lab of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China
  • 9 Chest Department, Taipei Veterans General Hospital and School of Medicine, National Yang Ming University, Taipei, Taiwan
  • 10 Division of Pulmonary and Critical Care Medicine, Philippine Heart Center, Quezon City, Philippines
Asia Pac Fam Med, 2015;14(1):4.
PMID: 25937817 DOI: 10.1186/s12930-015-0020-9


Chronic obstructive pulmonary disease (COPD) is a clinical syndrome encompassing a group of chronic, progressive, and debilitating respiratory conditions, that are characterized by incompletely reversible airflow limitation. Within the Asia-Pacific region, prevalence estimates have been derived using various protocols and study methods, and there is little data on the impact of COPD exacerbations. This study aimed to provide a comprehensive picture of the current prevalence and burden of COPD in this region.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.